Global Single-use Bioprocessing Market Outlook Report 2023-2028 Featuring Key Vendors - Thermo Fisher Scientific, Sartorius Stedim Biotech, Danaher, Merck, & Avantor

Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028" report has been added to's offering.

The global single-use bioprocessing market is expected to reach a value of $26.54 billion by 2028 from $9 billion in 2022, growing at a CAGR of 19.74% from 2022 to 2028

The global landscape of the single-use bioprocessing market is characterized by its dynamism, presenting significant growth prospects for industry participants. Amid a competitive arena featuring both global and local players, a handful of major global stakeholders command substantial market shares, offering an extensive array of single-use technologies.

The market's potential for expansion has attracted the attention of new entrants, fueling heightened competition. This surge in competitive dynamics is projected to drive notable product innovation among single-use technology manufacturers, including the development of high-capacity single-use bioreactors to cater to growing manufacturing volumes.

The single-use bioprocessing market in North America is witnessing remarkable expansion and is poised to maintain this trajectory throughout the forecast period. Fueled by a surge in demand for biologics, particularly from the elderly patient demographic, substantial investments in research and development by biopharmaceutical companies, and the approaching patent expirations of biologic drugs, the North American single-use bioprocessing market is positioned for robust growth.

Notably, North America, with a spotlight on the United States, stands as a hub for in-house biopharmaceutical manufacturing facilities. This environment has led to a widespread adoption of disposable solutions, spanning basic peripherals and advanced single-use systems such as mixing systems, bioreactors, and cell culture systems in recent years.


New Product Launches

Technological advances have been key in introducing new single-use bioprocess consumables worldwide. Players in the single-use bioprocessing market have launched new products that make single-use bioprocessing safer, easier, and more efficient than ever before. Such factors have allowed companies to gain market share by meeting market demands.

Market participants apply for patents on single-use disposable bioprocessing products that protect novel designs. The increasing availability of single-use technology for production applications and the launch of new products creates an environment where companies can quickly and easily adopt the technology and begin reaping the benefits.

Companies can now reduce costs and improve efficiency in their production processes by replacing traditional, labor-intensive methods with single-use technology.

Increasing Strategic Acquisitions and Collaborations

The strategic acquisition of single-use technology can enhance adoption across biopharmaceuticals. Single-use technology is a cost-effective and efficient way to streamline operations, reduce waste, and improve quality control. By strategically acquiring high-quality single-use technology, organizations can increase their competitive advantage while reducing costs and increasing efficiency.

The strategic acquisition of single-use technology can increase the visibility and control of processes, resulting in increased transparency and compliance with industry regulations. The strategic acquisition of single-use technology can be a powerful tool for organizations looking to reduce costs, increase efficiency, and improve their competitive advantage.

In addition, the industry players are adopting partnership strategies to facilitate access to local single-use bioprocessing markets.

Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars

The growing biomanufacturing capacity and uptake of biopharmaceuticals and biosimilars drive the single-use bioprocessing market. Single-use bioprocessing provides a valuable platform for producing biopharmaceuticals, biotherapeutics, vaccines, monoclonal antibodies, and biosimilars.

With advances in biomanufacturing, single-use bioprocessing offers greater flexibility, shorter process times, improved scalability, lower capital costs, and reduced product contamination risks. Additionally, single-use bioprocessing eliminates the need for extensive cleaning and sterilization of equipment, thus reducing operational costs.



Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry.

This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing.

This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.


The global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others.

Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs.

Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single-use bioprocessing particularly attractive for mAb production.


The biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market.

This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing.

However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.


The global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry.

It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.


The upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest.

Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies with a more efficient and cost-effective workflow.

Key Attributes:

Report AttributeDetails
No. of Pages395
Forecast Period2022 - 2028
Estimated Market Value (USD) in 2022$9 Billion
Forecasted Market Value (USD) by 2028$26.54 Billion
Compound Annual Growth Rate19.7%
Regions CoveredGlobal

Market Opportunities & Trends

  • Single-Use Technology in Cell and Gene Therapy
  • Increasing Demand for Continuous Bioprocessing
  • Technological Advances in Single-Use Bioprocessing (Sub)
  • New Product Launches
  • Increasing Strategic Acquisitions and Collaborations

Market Growth Enablers

  • Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars
  • Lower Capital Investment in Suts Over Multi-Use Platforms and Less Floor Space Requirements
  • Increased Acceptance of Sus to Enhance Biomanufacturing Productivity and Efficiency
  • Reduced Water Consumption and Lesser Environmental Impact of Single-Use Technologies

Market Restraints

  • The Changing Scale of Single-Use Operations
  • Low Strength of Supply Chain and Lack of Standardization
  • Issues Related to Leachables and Extractables

Key Company Profiles

  • Thermo Fisher Scientific
  • Sartorius Stedim Biotech
  • Danaher
  • Merck KGaA
  • Avantor

Other Prominent Vendors

  • 3i Group
  • 3M
  • ABEC
  • Adolf Kuhner
  • AdvantaPure
  • Barry-Wehmiller Companies
  • Broadley-James
  • Celltainer Biotech
  • CerCell A/S
  • CESCO Bioengineering
  • Charter Medical
  • Colder Products Company
  • Corning
  • Distek
  • DrM, Dr. Mueller
  • Emerson Electric
  • Entegris
  • Eppendorf
  • Foxx Life Sciences
  • Getinge
  • Holland Applied Technologies
  • Lonza
  • New Horizon Biotech
  • OmniBRx Biotechnologies
  • PendoTECH
  • PBS Biotech
  • Repligen
  • Saint-Gobain
  • Sentinel Process Systems
  • Solaris Biotechnology
  • Watson-Marlow Fluid Technology Solutions
  • Weigao Group
  • W.L. Gore & Associates

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Single-use Bioprocessing Market

Contact Data